Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products

被引:1
|
作者
Tu, Chi-Ming [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Off Med Error Prevent & Risk Management,Div Med E, 10903 New Hampshire Ave,Mailstop 4447,Bldg 22, Silver Spring, MD 20993 USA
关键词
prescribing practice; proprietary name; OTC drug; drug name confusion; medication error; PHYSICIAN SERVICES; PATTERNS; SWITCH;
D O I
10.1177/2168479018762376
中图分类号
R-058 [];
学科分类号
摘要
Background: To identify if proprietary names are used by health care practitioners when prescribing over-the-counter (OTC) drug products. These findings can inform evaluation of proposed proprietary names for both prescription and OTC drug products. Methods: QuintilesIMS OTC International Market Tracking (QuintilesIMS OTCIMS) was used to identify top OTC drug products sold to the consumers from US retail store outlets in year 2011. QuintilesIMS's Vector One: National (VONA) was used to identify prescribers' use of proprietary names by examining drug use data from 2003 to 2011 for the top OTC products identified from QuintilesIMS OTCIMS. Results: Of the 29 OTC drug products that have drug utilization data available, the data showed prescribers' use of proprietary names every year from 2003 to 2011 for 24 OTC drug products, and from 2004 to 2011 for 2 OTC drug products. The drug use data showed the use of proprietary name in some years but not all years from 2003 to 2011 for the remaining 3 OTC drug products. For the OTC drug products studied, prescribers used proprietary names for OTC products when prescribing them, and the use of proprietary names on prescriptions can vary during a 9-year period. Conclusion: This research identified that prescribers do prescribe OTC drug products using proprietary names. This prescribing practice confirms the need for the pharmaceutical industry, industry consultants, and regulators to consider the proprietary names of OTC drug products when formulating and evaluating new proprietary names for drugs.
引用
收藏
页码:132 / 137
页数:6
相关论文
共 50 条
  • [41] The Preferred Order of Over-the-Counter (OTC) Pharmaceutical Label Components
    J. William
    S. Michael
    [J]. Drug information journal : DIJ / Drug Information Association, 1997, 31 (3): : 973 - 988
  • [42] Prescription versus over-the-counter (OTC) in Swedish paracetamol poisoning
    Lindeman, Erik
    Hernandez, Paula
    Salmonson, Helene
    Grass, Johanna Nordmark
    [J]. CLINICAL TOXICOLOGY, 2019, 57 (06) : 496 - 496
  • [43] READABILITY OF PATIENT INFORMATION LEAFLETS ON OVER-THE-COUNTER (OTC) MEDICINES
    BRADLEY, B
    SINGLETON, M
    PO, ALW
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (01) : 7 - 15
  • [44] Summary of: Over-the-counter (OTC) bruxism splints available on the Internet
    Wassell, R. W.
    Verhees, L.
    Lawrence, K.
    Davies, S.
    Lobbezoo, F.
    [J]. BRITISH DENTAL JOURNAL, 2014, 216 (11) : 642 - 643
  • [45] Issues Related to Monitoring the Safety of Over-The-Counter (OTC) Medicines
    Christine Bond
    Philip Hannaford
    [J]. Drug Safety, 2003, 26 : 1065 - 1074
  • [46] Over-the-counter melatonin products and contamination
    Naylor, S
    Gleich, GJ
    [J]. AMERICAN FAMILY PHYSICIAN, 1999, 59 (02) : 284 - +
  • [47] Over-the-Counter Analgesic Use
    De Broe, Marc E.
    Elseviers, Monique M.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (10): : 2098 - 2103
  • [48] Correlates to over-the-counter drug use among college students
    Vidourek, Rebecca A.
    King, Keith A.
    Burbage, Michelle L.
    [J]. JOURNAL OF SUBSTANCE USE, 2015, 20 (05) : 310 - 314
  • [49] SAFETY EVALUATION OF OVER-THE-COUNTER PRODUCTS
    DESALVA, SJ
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1985, 5 (01) : 101 - 108
  • [50] Over-the-counter Topical Products in Dermatology
    Greenberg, Sophie A.
    [J]. CUTIS, 2020, 105 (04): : E35 - E36